Literature DB >> 9734651

Long-term detection of microchimaerism in peripheral blood after pretransplantation blood transfusion.

S F Vervoordeldonk1, K Doumaid, E B Remmerswaal, I J ten Berge, J M Wilmink, L P de Waal, C J Boog.   

Abstract

Renal allograft survival is prolonged after pretransplantation blood transfusion. The aim of this study was to test retrospectively the development and persistence of microchimaerism after pretransplantation blood transfusion and to assess whether the type of blood transfusion (partially matched [= sharing of at least one HLA-B and one HLA-DR antigen between blood donor and recipient] versus mismatched) influences the (continued) presence of donor-type cells. A sensitive nested PCR technique based on HLA-DRB1 allele-specific amplification using sequence-specific primers (detection level: one donor cell among 10(5) recipient cells) for detection of donor cells was implemented in our laboratory. We studied 21 patients for microchimaerism in the peripheral blood compartment, following blood transfusion. Our preliminary data show that microchimaerism was detectable up to 8 weeks after blood transfusion. In all patients receiving a partially matched blood transfusion, donor-type cells were detected in the first week after transfusion, in 7/8 patients 2-4 weeks after transfusion, and in some patients up to 8 weeks after transfusion. After mismatched transfusion a tendency to shorter duration of microchimaerism was observed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9734651     DOI: 10.1046/j.1365-2141.1998.00862.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

Review 1.  Transfusion-associated microchimerism: the hybrid within.

Authors:  Evan M Bloch; Rachael P Jackman; Tzong-Hae Lee; Michael P Busch
Journal:  Transfus Med Rev       Date:  2012-10-24

2.  The occurrence of fetal microchimeric cells in endometrial tissues is a very common phenomenon in benign uterine disorders, and the lower prevalence of fetal microchimerism is associated with better uterine cancer prognoses.

Authors:  Ilona Hromadnikova; Katerina Kotlabova; Petra Pirkova; Pavla Libalova; Zdenka Vernerova; Bohuslav Svoboda; Eduard Kucera
Journal:  DNA Cell Biol       Date:  2013-11-27       Impact factor: 3.311

3.  Molecular screening for 22Q11.2 deletion syndrome in patients with congenital heart disease.

Authors:  Janaína Huber; Vivian Catarino Peres; Alexandre Luz de Castro; Tiago Jeronimo dos Santos; Lauro da Fontoura Beltrão; Angélica Cerveira de Baumont; Silvia Liliana Cossio; Tiago Pires Dalberto; Mariluce Riegel; Andrés Delgado Cañedo; Beatriz D'Agord Schaan; Lucia Campos Pellanda
Journal:  Pediatr Cardiol       Date:  2014-06-01       Impact factor: 1.655

4.  Cytogenomic Evaluation of Subjects with Syndromic and Nonsyndromic Conotruncal Heart Defects.

Authors:  Karen Regina de Souza; Rafaella Mergener; Janaina Huber; Lucia Campos Pellanda; Mariluce Riegel
Journal:  Biomed Res Int       Date:  2015-06-07       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.